Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A risk-benefit assessment of metformin in type 2 diabetes mellitus.
Howlett HC, Bailey CJ. Howlett HC, et al. Drug Saf. 1999 Jun;20(6):489-503. doi: 10.2165/00002018-199920060-00003. Drug Saf. 1999. PMID: 10392666 Review.
Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.
Davidson JA, Scheen AJ, Howlett HC. Davidson JA, et al. Among authors: howlett hc. Drug Saf. 2004;27(15):1205-16. doi: 10.2165/00002018-200427150-00004. Drug Saf. 2004. PMID: 15588116 Review.
Metformin therapy and clinical uses.
Scarpello JH, Howlett HC. Scarpello JH, et al. Among authors: howlett hc. Diab Vasc Dis Res. 2008 Sep;5(3):157-67. doi: 10.3132/dvdr.2008.027. Diab Vasc Dis Res. 2008. PMID: 18777488 Free article. Review.
Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Marre M, Howlett H, Lehert P, Allavoine T. Marre M, et al. Diabet Med. 2002 Aug;19(8):673-80. doi: 10.1046/j.1464-5491.2002.00774.x. Diabet Med. 2002. PMID: 12147149 Clinical Trial.
Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.
Garber A, Marre M, Blonde L, Allavoine T, Howlett H, Lehert P, Cornes M. Garber A, et al. Diabetes Obes Metab. 2003 May;5(3):171-9. doi: 10.1046/j.1463-1326.2003.00259.x. Diabetes Obes Metab. 2003. PMID: 12681024
Effects of metformin on bile salt transport by monolayers of human intestinal Caco-2 cells.
Carter D, Howlett HC, Wiernsperger NF, Bailey C. Carter D, et al. Among authors: howlett hc. Diabetes Obes Metab. 2002 Nov;4(6):424-7. doi: 10.1046/j.1463-1326.2002.00223.x. Diabetes Obes Metab. 2002. PMID: 12406042
Beta-cell response to metformin-glibenclamide combination tablets (Glucovance) in patients with type 2 diabetes.
Bruce S, Park JS, Fiedorek FT, Howlett HC. Bruce S, et al. Among authors: howlett hc. Int J Clin Pract. 2006 Jul;60(7):783-90. doi: 10.1111/j.1742-1241.2006.00994.x. Int J Clin Pract. 2006. PMID: 16846398 Clinical Trial.
Metformin in the management of type 2 diabetes.
Howlett HC. Howlett HC. Diabet Med. 1989 Mar;6(2):179-80. Diabet Med. 1989. PMID: 2522868 No abstract available.
Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis.
Campbell IW, Howlett HC. Campbell IW, et al. Among authors: howlett hc. Diabetes Metab Rev. 1995 Sep;11 Suppl 1:S57-62. doi: 10.1002/dmr.5610110509. Diabetes Metab Rev. 1995. PMID: 8529486 No abstract available.
12 results
Jump to page